GPR19 Polyclonal Antibody

    • Catalog No.:YT2007
    • Applications:WB;IHC;IF;ELISA
    • Reactivity:Human;Mouse;Rat
      • Target:
      • GPR19
      • Gene Name:
      • GPR19
      • Protein Name:
      • Probable G-protein coupled receptor 19
      • Human Gene Id:
      • 2842
      • Human Swiss Prot No:
      • Q15760
      • Mouse Swiss Prot No:
      • Q61121
      • Immunogen:
      • The antiserum was produced against synthesized peptide derived from human GPR19. AA range:361-410
      • Specificity:
      • GPR19 Polyclonal Antibody detects endogenous levels of GPR19 protein.
      • Formulation:
      • Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
      • Source:
      • Polyclonal, Rabbit,IgG
      • Dilution:
      • WB 1:500 - 1:2000. IHC 1:100 - 1:300. IF 1:200 - 1:1000. ELISA: 1:5000. Not yet tested in other applications.
      • Purification:
      • The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
      • Concentration:
      • 1 mg/ml
      • Storage Stability:
      • -15°C to -25°C/1 year(Do not lower than -25°C)
      • Other Name:
      • GPR19;Probable G-protein coupled receptor 19;GPR-NGA
      • Observed Band(KD):
      • 47kD
      • Background:
      • function:Orphan receptor.,similarity:Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Abundant expression in the brain.,
      • Function:
      • function:Orphan receptor.,similarity:Belongs to the G-protein coupled receptor 1 family.,tissue specificity:Abundant expression in the brain.,
      • Subcellular Location:
      • Cell membrane; Multi-pass membrane protein.
      • Expression:
      • Abundant expression in the brain.
      • Products Images
      • Western Blot analysis of various cells using GPR19 Polyclonal Antibody cells nucleus extracted by Minute TM Cytoplasmic and Nuclear Fractionation kit (SC-003,Inventbiotech,MN,USA).
      • Western blot analysis of lysates from MCF-7, HUVEC, and HepG2 cells, using GPR19 Antibody. The lane on the right is blocked with the synthesized peptide.